dr. tyson on rationale for neoadjuvant chemotherapy in bladder cancer
Published 6 years ago • 326 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
8:21
introduction: neoadjuvant chemotherapy in bladder cancer
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
6:30
neoadjuvant therapy in muscle-invasive bladder cancer
-
8:00
neoadjuvant and adjuvant therapy in muscle-invasive bladder cancer
-
1:24
next steps in neoadjuvant chemotherapy for muscle-invasive bladder cancer
-
10:32
what are neoadjuvant and adjuvant chemotherapy for bladder cancer?
-
2:48
using biomarkers to identify bladder cancer patients for neoadjuvant therapy
-
15:22
neoadjuvant immune checkpoint inhibition for muscle invasive bladder cancer
-
1:02:16
ivumed vvp: neoadjuvant chemotherapy in bladder cancer
-
5:25
neoadjuvant cisplatin-based chemotherapy for muscle invasive bladder cancer
-
2:16
dr. matthew mossanen on the impact of neoadjuvant chemotherapy on bladder cancer outcomes
-
2:08
dr. david nanus on atezolizumab for urothelial bladder cancer
-
1:06:18
biomarker-guided neoadjuvant therapy for bladder cancer
-
3:29
contemporary neoadjuvant chemotherapy for bladder cancer
-
4:38
impact of neoadjuvant chemo on pathological staging and survival in sarcomatoid bladder cancer
-
4:39
durvalumab as neoadjuvant therapy for muscle-invasive bladder cancer
-
31:06
bladder cancer | 2022 oneoncology conference
-
1:36
dr. galsky discusses neoadjuvant immunotherapy in bladder cancer
-
1:01
dr. o’neil on adjuvant therapy in bladder cancer